DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent 03/09/2018 David Branigan A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading -> Posts navigation Newer posts
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent 03/09/2018 David Branigan A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading -> Posts navigation Newer posts
Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent 03/09/2018 David Branigan A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading -> Posts navigation Newer posts
Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent 03/09/2018 David Branigan A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading -> Posts navigation Newer posts
MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent 03/09/2018 David Branigan A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading -> Posts navigation Newer posts